Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extracellular proteolysis in cancer: Proteases, substrates, and mechanisms in tumor progression and metastasis
Evette S. Radisky
Journal of Biological Chemistry (2024) Vol. 300, Iss. 6, pp. 107347-107347
Open Access | Times Cited: 24

Showing 24 citing articles:

Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy
Nimeet Desai, Deepak Kumar Sahel, Bhakti Kubal, et al.
Advanced Therapeutics (2025)
Open Access | Times Cited: 2
The Complex Tumor Microenvironment in Ovarian Cancer: Therapeutic Challenges and Opportunities
Bianca Garlisi, Sylvia Lauks, Caroline Aitken, et al.
Current Oncology (2024) Vol. 31, Iss. 7, pp. 3826-3844
Open Access | Times Cited: 13
Potential of MMP-2 and MMP-9 Gelatinase Blockade as a Therapeutic Strategy in Fibrosarcoma Treatment: A Decadal Review
Alireza Shoari
Targets (2024) Vol. 2, Iss. 2, pp. 104-125
Open Access | Times Cited: 9
Cathepsins: Novel opportunities for antibody therapeutics in cancer
Timothée David, Pénélope Desroys du Roure, Aude Mallavialle, et al.
British Journal of Pharmacology (2025)
Closed Access | Times Cited: 1
Matrix metalloproteinases: Master regulators of tissue morphogenesis
P Sreesada, Vandana, B Krishnan, et al.
Gene (2024) Vol. 933, pp. 148990-148990
Closed Access | Times Cited: 4
Decoding the MMP14 Integrin Link: Key Player in the Secretome Landscape
Stephan Niland, Johannes A. Eble
Matrix Biology (2025)
Open Access
From Bench to Bedside: Transforming Cancer Therapy with Protease Inhibitors
Alireza Shoari
Targets (2025) Vol. 3, Iss. 1, pp. 8-8
Open Access
Affibody-based HER2 prodrug shows conditional cytotoxic effect on HER2-positive cancer cells
Cornelia Westerberg, Anna Mestre Borras, Stefan Ståhl, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151660-151660
Open Access
Utilizing Two Electrokinetic Techniques on a Single Device for Detection of Extracellular Vesicle‐Associated Protease Activity
Ella Stimson, Delaney Shea, Michelle M. Gomes, et al.
Small (2025)
Open Access
Matrix metalloproteinase-driven epithelial-mesenchymal transition: implications in health and disease
Ghazaleh Khalili‐Tanha, Evette S. Radisky, Derek C. Radisky, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Proteomic analysis of blood plasma as a tool for personalized diagnosis of lung adenocarcinoma
D. Korobkov, А. С. Кононихин, Savva Semenov, et al.
Advances in molecular oncology (2025) Vol. 12, Iss. 1, pp. 96-108
Open Access
Stimuli-Responsive Prodrugs with Self-Immolative Linker for Improved Cancer Therapy
Xu Wenting, Ang Jia, Zhixian Lei, et al.
European Journal of Medicinal Chemistry (2024) Vol. 279, pp. 116928-116928
Closed Access | Times Cited: 3
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension
Jason Shirian, Alexandra Hockla, Justyna Trynda, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1187-1187
Open Access | Times Cited: 2
Remodeling of the extracellular matrix by serine proteases as a prerequisite for cancer initiation and progression
Tomasz Wenta, Paulina Nastały, Barbara Lipińska, et al.
Matrix Biology (2024) Vol. 134, pp. 197-219
Closed Access | Times Cited: 2
Targeting Invasion: The Role of MMP-2 and MMP-9 Inhibition in Colorectal Cancer Therapy
Alireza Shoari, Arghavan Ashja Ardalan, Alexandra M. Dimesa, et al.
Biomolecules (2024) Vol. 15, Iss. 1, pp. 35-35
Open Access | Times Cited: 2
Improving Circulation Half-Life of Therapeutic Candidate N-TIMP2 by Unfolded Peptide Extension
Jason Shirian, Alexandra Hockla, Justyna Trynda, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Substrate O‐glycosylation actively regulates extracellular proteolysis
Elizabeta Madzharova, Fabio Sabino, Konstantinos Kalogeropoulos, et al.
Protein Science (2024) Vol. 33, Iss. 8
Open Access | Times Cited: 1
Recent discovery of natural substances with cathepsin L-inhibitory activity for cancer metastasis suppression
Jun-Young Park, Kyung‐Min Park
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116754-116754
Closed Access | Times Cited: 1
Shaping the Landscape of Lung Cancer: The Role and Therapeutic Potential of Matrix Metalloproteinases
Arghavan Ashja Ardalan, Ghazaleh Khalili‐Tanha, Alireza Shoari
International Journal of Translational Medicine (2024) Vol. 4, Iss. 4, pp. 661-679
Open Access | Times Cited: 1
Tryptase and tumor angiogenesis
Doménico Ribatti
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 1
Elucidating key determinants of engineered scFv antibody in MMP-9 binding using high throughput screening and machine learning
Masoud Kalantar, Ifthichar Kalanther, Sachin Kumar, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Determining key residues of engineered scFv antibody variants with improved MMP-9 binding using deep sequencing and machine learning
Masoud Kalantar, Ifthichar Kalanther, Sachin Kumar, et al.
Computational and Structural Biotechnology Journal (2024) Vol. 23, pp. 3759-3770
Open Access
Association between cathepsins and cardiomyopathy: A Mendelian randomization study
Qiuyun Chen, Xiu‐Ming Yang, Qingyu Zhang, et al.
Medicine (2024) Vol. 103, Iss. 51, pp. e40974-e40974
Open Access
Mast cell proteases and metastasis
Doménico Ribatti
Pathology - Research and Practice (2024) Vol. 266, pp. 155801-155801
Closed Access
Page 1

Scroll to top